Short Interest in PMGC Holdings Inc. (NASDAQ:ELAB) Increases By 144.4%

PMGC Holdings Inc. (NASDAQ:ELAB) saw a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 809,201 shares, an increase of 144.4% from the June 30th total of 331,075 shares. Currently, 69.8% of the shares of the company are sold short. Based on an average daily trading volume, of 10,484,044 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of PMGC in a research report on Friday, June 26th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

PMGC Price Performance

Shares of NASDAQ ELAB opened at $0.88 on Thursday. The stock has a market cap of $1.02 million, a P/E ratio of -0.01 and a beta of -0.23. The firm’s 50-day simple moving average is $1.33 and its 200 day simple moving average is $5.76. PMGC has a fifty-two week low of $0.84 and a fifty-two week high of $309.12. The company has a quick ratio of 1.43, a current ratio of 1.45 and a debt-to-equity ratio of 0.03.

PMGC (NASDAQ:ELAB) last announced its earnings results on Thursday, May 14th. The company reported ($11.22) earnings per share (EPS) for the quarter. The company had revenue of $0.68 million for the quarter.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.